PRT-811
- Generic Name
- PRT-811
A Study of PRT811 in Participants With Advanced Solid Tumors, CNS Lymphoma and Gliomas
- First Posted Date
- 2019-09-13
- Last Posted Date
- 2023-04-05
- Lead Sponsor
- Prelude Therapeutics
- Target Recruit Count
- 86
- Registration Number
- NCT04089449
- Locations
- 🇺🇸
The Ohio State University and Wexner Medical Center, Columbus, Ohio, United States
🇺🇸Northwestern Memorial Hospital, Chicago, Illinois, United States
🇺🇸University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath